Simultaneous treatment of hypertension and dyslipidaemia may help to reduce overall cardiovascular risk: focus on amlodipine/atorvastatin single‐pill therapy

MR Cowie - International journal of clinical practice, 2005 - Wiley Online Library
Single‐pill amlodipine besylate/atorvastatin calcium (Caduet®, Pfizer Inc, NY, USA) is the
first therapy aimed at the simultaneous treatment of hypertension (HTN) and dyslipidaemia …

[引用][C] Simultaneous treatment of hypertension and dyslipidaemia may help to reduce overall cardiovascular risk: focus on amlodipine/atorvastatin single-pill therapy

MR COWIE - International journal of clinical practice (Esher), 2005 - pascal-francis.inist.fr
Simultaneous treatment of hypertension and dyslipidaemia may help to reduce overall
cardiovascular risk : focus on amlodipine/atorvastatin single-pill therapy CNRS Inist Pascal-Francis …

[引用][C] Simultaneous treatment of hypertension and dyslipidaemia may help to reduce overall cardiovascular risk: focus on amlodipine/atorvastatin single-pill therapy

MR Cowie - International Journal of Clinical Practice, 2005 - cir.nii.ac.jp
Simultaneous treatment of hypertension and dyslipidaemia may help to reduce overall
cardiovascular risk: focus on amlodipine/atorvastatin single-pill therapy | CiNii Research CiNii …

Simultaneous treatment of hypertension and dyslipidaemia may help to reduce overall cardiovascular risk: focus on amlodipine/atorvastatin single-pill therapy.

MR Cowie - International Journal of Clinical Practice, 2005 - search.ebscohost.com
Single-pill amlodipine besylate/atorvastatin calcium (Caduet< sup>®, Pfizer Inc, NY, USA) is
the first therapy aimed at the simultaneous treatment of hypertension (HTN) and …

Simultaneous treatment of hypertension and dyslipidaemia may help to reduce overall cardiovascular risk: focus on amlodipine/atorvastatin single-pill therapy

MR Cowie - International journal of clinical practice, 2005 - pubmed.ncbi.nlm.nih.gov
Single-pill amlodipine besylate/atorvastatin calcium (Caduet), Pfizer Inc, NY, USA) is the first
therapy aimed at the simultaneous treatment of hypertension (HTN) and dyslipidaemia …

Simultaneous treatment of hypertension and dyslipidaemia may help to reduce overall cardiovascular risk: focus on amlodipine/atorvastatin single-pill therapy.

MR Cowie - International Journal of Clinical Practice, 2005 - europepmc.org
Single-pill amlodipine besylate/atorvastatin calcium (Caduet), Pfizer Inc, NY, USA) is the first
therapy aimed at the simultaneous treatment of hypertension (HTN) and dyslipidaemia …

[引用][C] Simultaneous treatment of hypertension and dyslipidaemia may help to reduce overall cardiovascular risk: focus on amlodipine/atorvastatin single-pill therapy

MR COWIE - International journal of clinical practice, 2005 - Wiley-Blackwell